子宫内避孕器市场、机会、成长动力、产业趋势分析与预测，2024-2032

Intrauterine Devices Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月02日 | 出版商:

Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于意外怀孕发生率上升和政府的支持性倡议，全球子宫内避孕器市场在 2023 年价值 43 亿美元，到 2032 年将达到 101 亿美元，2024 年至 2032 年复合年增长率为 10.3%。由于意外怀孕凸显了有效避孕的必要性，越来越多人开始使用子宫内的避孕器来进行可靠、长期的预防。此外，促进计划生育和生殖健康的政府计划提高了子宫内避孕器的可及性和认识。这些综合因素可能会促进子宫内避孕器的采用，促进市场扩张并满足对有效避孕解决方案不断增长的需求。

子宫内避孕器产业根据产品、年龄层、最终用途和地区进行分类。

由于其有效性和相对于传统方法的额外优势，荷尔蒙子宫内避孕器细分市场在 2023 年将获得 23 亿美元的收入。荷尔蒙子宫内避孕器可提供长期避孕作用，同时还具有减少月经出血和缓解经痛等好处，使其对使用者极具吸引力。荷尔蒙子宫内避孕器技术的进步以及人们对这些益处的认识不断提高，进一步推动了其普及。随着对更有效和用户友好的避孕选择的需求不断增长，激素子宫内避孕器将引领市场。

由于对专业医疗服务和综合生殖保健的高需求的推动，到2023年，医院部门将占据46.8%的份额。医院提供一系列专业服务，包括子宫内避孕器的放置和管理，吸引寻求可靠和专业避孕解决方案的患者。此外，医院配备了先进的设施和训练有素的医疗保健专业人员，提高了子宫内避孕器的采用率。随着医疗机构继续优先考虑计划生育，医院部门将主导市场。

由于先进的医疗基础设施、对生殖健康的高度认识以及现代避孕方法的广泛采用，北美子宫内避孕器市场在 2023 年累计达到 15 亿美元。该地区受益于医疗保健和计划生育服务的大量投资，增强了子宫内避孕器的可近性和教育。此外，有利的政府政策和对女性健康的强烈关注进一步推动市场成长。北美强大的医疗保健系统和积极主动的方法使其成为子宫内避孕器行业的关键贡献者。

产业生态系统分析
产业影响力
- 成长动力
  - 女性对各种子宫内避孕器应用的认识不断提高
  - 意外怀孕率很高
  - 政府预防意外堕胎和怀孕的倡议
  - 越来越倾向于计划性延迟妊娠
- 产业陷阱与挑战
  - 设备成本高
  - 多种健康问题的风险
  - 保险范围和获取途径的可变性
成长潜力分析
技术景观
未来市场趋势
监管环境
- 我们
- 欧洲
- 亚太地区
报销场景
- 北美洲
- 欧洲
- 亚太地区
定价分析
差距分析
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
含铜子宫内避孕器
荷尔蒙子宫内避孕器

第 6 章：市场估计与预测：按年龄划分，2021 - 2032

主要趋势
15-19日
20-24日
25-29日
30-34
35-39
40-44
45+

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院
妇科诊所
社区健康服务中心

第 8 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Allergan (AbbVie Inc.)
Bayer AG
Contrel Europe
CooperSurgical Inc.
Durbin
EUROGINE, SL
Gima SpA
HLL Lifecare Limited
Meril Life Sciences Pvt. Ltd.
Mona Lisa NV
Mylan NV (Viatris)
OCON Medical Ltd.
Pregna International Ltd.
Prosan International BV
SMB Corporation of India

简介目录

Product Code: 5451

The Global Intrauterine Devices Market, worth USD 4.3 billion in 2023, will achieve USD 10.1 billion by 2032 at a 10.3% CAGR from 2024 to 2032, owing to the rising incidence of unplanned pregnancies and supportive government initiatives. As unplanned pregnancies highlight the need for effective contraception, more individuals are turning to IUDs for reliable, long-term prevention. Additionally, government programs promoting family planning and reproductive health enhance accessibility and awareness of IUDs. These combined factors are likely to boost the adoption of IUDs, contributing to the market's expansion and addressing the growing demand for effective contraceptive solutions.

The intrauterine devices industry is segregated on the basis of product, age group, end use , and region.

The hormonal IUD segment secured USD 2.3 billion in 2023 due to its effectiveness and additional benefits over traditional methods. Hormonal IUDs provide long-term contraception while also offering benefits like reduced menstrual bleeding and alleviation of menstrual cramps, making them highly appealing to users. Advances in hormonal IUD technology and increasing awareness of these benefits further drive their popularity. As demand for more effective and user-friendly contraceptive options grows, hormonal IUDs will lead the market.

The hospital segment held 46.8% share in 2023, driven by the high demand for professional medical services and comprehensive reproductive health care. Hospitals offer a range of specialized services, including the insertion and management of IUDs, attracting patients seeking reliable and expert contraceptive solutions. Additionally, hospitals are equipped with advanced facilities and trained healthcare professionals, enhancing the adoption of IUDs. As healthcare facilities continue to prioritize family planning, the hospital segment will dominate the market.

North America intrauterine devices market accumulated USD 1.5 billion in 2023, fueled by its advanced healthcare infrastructure, high awareness of reproductive health, and widespread adoption of modern contraceptive methods. The region benefits from significant investments in healthcare and family planning services, enhancing accessibility and education about IUDs. Additionally, favorable government policies and a strong focus on women's health further drive market growth. North America's robust healthcare system and proactive approach make it a key contributor to the intrauterine devices industry.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising awareness among women regarding various IUD applications
  - 3.2.1.2 High number of unintended pregnancies
  - 3.2.1.3 Government initiatives for the prevention of unwanted abortions and pregnancies
  - 3.2.1.4 Growing inclination towards planned delayed pregnancy
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of device
  - 3.2.2.2 Risk of several health issues
  - 3.2.2.3 Variability in insurance coverage and access
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Future market trends
3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
- 3.6.3 Asia Pacific
3.7 Reimbursement scenario
- 3.7.1 North America
- 3.7.2 Europe
- 3.7.3 Asia Pacific
3.8 Pricing analysis
3.9 Gap analysis
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Copper IUD
5.3 Hormonal IUD

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 15-19
6.3 20-24
6.4 25-29
6.5 30-34
6.6 35-39
6.7 40-44
6.8 45+

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Gynecology clinics
7.4 Community health care centers

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa